Sol-Gel Technologies Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Sol-Gel Technologies Ltd., a foreign private issuer, covers the month of February 2018. The report was filed on February 26, 2018, and primarily addresses changes to the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure regarding corporate governance and does not contain financial statements or performance metrics.
Material Changes
- Board Resignation: Ms. Yael Baratz resigned from the Board of Directors for personal reasons, effective February 22, 2018.
- Board Appointment: Ms. Yaffa Krindel was appointed to the Board of Directors to replace Ms. Baratz, effective immediately.
Management Commentary and Background
The Company highlighted the extensive background of the new appointee, Ms. Yaffa Krindel, who possesses over 25 years of experience in the Israeli high-tech and medical sectors. Her qualifications include:
- Current board service at Itamar Medical Ltd. (TASE), BGN Technologies Ltd., and two medical device start-ups.
- Prior experience as Partner and Managing Partner of Star Ventures (1997–2007).
- Former CFO and VP Finance roles at Lannet Data Communications Ltd. and BreezeCOM Ltd., both previously traded on Nasdaq.
- Education includes an M.B.A. from Tel Aviv University and a B.A. in Economics and Japanese Studies from the Hebrew University in Jerusalem.
Key Facts for Investor Verification
- Confirm the effective date of Ms. Krindel's appointment and her specific committee assignments, if any.
- Verify the impact of the board change on the Company's strategic direction, particularly regarding its medical technology focus.
- Review subsequent filings for any financial updates, as this document contains no financial data.